Chromatin immunoprecipitation and association study revealed a possible role of Runt-related transcription factor 3 in the ulcerative colitis of Chinese population

Clinical Immunology

Volumn 135, Issue 3, 2010, Pages 483-489

  Guo, Changcun ^a   Yao, Fangfang ^a   Wu, Kaichun ^a   Yang, Liping ^a   Zhang, Xin ^a   Ding, Jie ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Inflammatory bowel disease; OCTN; PPAR; RUNX3; Ulcerative colitis

Indexed keywords

ORGANIC CATION TRANSPORTER 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR RUNX3;

ADULT; ARTICLE; CHINESE; CHROMATIN IMMUNOPRECIPITATION; COLON MUCOSA; CONTROLLED STUDY; FEMALE; FETUS; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; COLITIS, ULCERATIVE; CORE BINDING FACTOR ALPHA 3 SUBUNIT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGANIC CATION TRANSPORT PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PPAR GAMMA;

EID: 77951880151     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.01.004     Document Type: Article

References (54)

1. Inoue K., Shiga T., and Ito Y. Runx transcription factors in neuronal development. Neural. Dev. 3 (2008 Aug 26) 20
2. Collins A., Littman D.R., and Taniuchi I. RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat. Rev. Immunol. 9 2 (2009 Feb) 106-115
3. Ito Y. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv. Cancer Res. 99 (2008) 33-76
4. Cho J.H., Nicolae D.L., Ramos R., Fields C.T., Rabenau K., Corradino S., Brant S.R., Espinosa R., LeBeau M., Hanauer S.B., Bodzin J., and Bonen D.K. Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease. Hum. Mol. Genet. 9 9 (2000 May 22) 1425-1432
5. Brenner O., Levanon D., Negreanu V., Golubkov O., Fainaru O., Woolf E., and Groner Y. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc. Natl. Acad. Sci. U. S. A. 101 45 (2004 Nov 9) 16016-16021
6. Weersma R.K., Zhou L., Nolte I.M., van der Steege G., van Dullemen H.M., Oosterom E., Bok L., Peppelenbosch M.P., Faber K.N., Kleibeuker J.H., and Dijkstra G. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5. Inflamm. Bowel. Dis. 14 12 (2008 Dec) 1615-1622
7. Puig-Kröger A., Domínguez-Soto A., Martínez-Muñoz L., Serrano-Gómez D., Lopez-Bravo M., Sierra-Filardi E., Fernández-Ruiz E., Ruiz-Velasco N., Ardavín C., Groner Y., Tandon N., Corbí A.L., and Vega M.A. RUNX3 negatively regulates CD36 expression in myeloid cell lines. J. Immunol. 177 4 (2006 Aug 15) 2107-2114
8. Fainaru O., Shseyov D., Hantisteanu S., and Groner Y. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc. Natl. Acad. Sci. U. S. A. 102 30 (2005 Jul 26) 10598-10603
9. Kugathasan S., Baldassano R.N., Bradfield J.P., Sleiman P.M., Imielinski M., Guthery S.L., Cucchiara S., Kim C.E., Frackelton E.C., Annaiah K., Glessner J.T., Santa E., Willson T., Eckert A.W., Bonkowski E., Shaner J.L., Smith R.M., Otieno F.G., Peterson N., Abrams D.J., Chiavacci R.M., Grundmeier R., Mamula P., Tomer G., Piccoli D.A., Monos D.S., Annese V., Denson L.A., Grant S.F., and Hakonarson H. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat. Genet. 40 10 (2008 Oct) 1211-1215
10. Shi Q., Cox L.A., Glenn J., Tejero M.E., Hondara V., Vandeberg J.L., and Wang X.L. Molecular pathways mediating differential responses to lipopolysaccharide between human and baboon arterial endothelial cells. Clin. Exp. Pharmacol. Physiol. (2009 Jul 24)
11. Noble C.L., Abbas A.R., Cornelius J., Lees C.W., Ho G.T., Toy K., Modrusan Z., Pal N., Zhong F., Chalasani S., Clark H., Arnott I.D., Penman I.D., Satsangi J., and Diehl L. Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut 57 10 (2008 Oct) 1398-1405
12. Li C.K., Pender S.L., Pickard K.M., Chance V., Holloway J.A., Huett A., Gonçalves N.S., Mudgett J.S., Dougan G., Frankel G., and MacDonald T.T. Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice. J. Immunol. 173 8 (2004 Oct 15) 5171-5179
13. Parente L., and Solito E. Annexin 1: more than an anti-phospholipase protein. Inflamm. Res. 53 4 (2004 Apr) 125-132
14. Vergnolle N., Pagès P., Guimbaud R., Chaussade S., Buéno L., Escourrou J., and Coméra C. Annexin 1 is secreted in situ during ulcerative colitis in humans. Inflamm. Bowel. Dis. 10 5 (2004 Sep) 584-592
15. Silverberg M.S., Cho J.H., Rioux J.D., McGovern D.P., Wu J., Annese V., Achkar J.P., Goyette P., Scott R., Xu W., Barmada M.M., Klei L., Daly M.J., Abraham C., Bayless T.M., Bossa F., Griffiths A.M., Ippoliti A.F., Lahaie R.G., Latiano A., Paré P., Proctor D.D., Regueiro M.D., Steinhart A.H., Targan S.R., Schumm L.P., Kistner E.O., Lee A.T., Gregersen P.K., Rotter J.I., Brant S.R., Taylor K.D., Roeder K., and Duerr R.H. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat. Genet. 41 2 (2009 Feb) 216-220
16. Arnett H.A., Escobar S.S., Gonzalez-Suarez E., Budelsky A.L., Steffen L.A., Boiani N., Zhang M., Siu G., Brewer A.W., and Viney J.L. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J. Immunol. 178 3 (2007 Feb 1) 1523-1533
17. Mochida A., Kinouchi Y., Negoro K., Takahashi S., Takagi S., Nomura E., Kakuta Y., Tosa M., and Shimosegawa T. Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1*1502. Tissue Antigens 70 2 (2007 Aug) 128-135
18. Jo Y., Matsumoto T., Yada S., Fujisawa K., Esaki M., Onai N., Matsushima K., and Iida M. CCR4 is an up-regulated chemokine receptor of peripheral blood memory CD4+ T cells in Crohn's disease. Clin. Exp. Immunol. 132 2 (2003 May) 332-338
19. Yuan Q., Bromley S.K., Means T.K., Jones K.J., Hayashi F., Bhan A.K., and Luster A.D. CCR4-dependent regulatory T cell function in inflammatory bowel disease. J. Exp. Med. 204 6 (2007 Jun 11) 1327-1334 Electronic publication 2007 Jun 4
20. Scarpa M., Behboo R., Angriman I., Cecchetto A., D'Incà R., Termini B., Barollo M., Ruffolo C., Polese L., Sturniolo G.C., and D'Amico D.F. Expression of costimulatory molecule CD80 in colonic dysplasia in ulcerative colitis: an immunosurveillance mechanism against colorectal cancer?. Int. J. Colorectal. Dis. 21 8 (2006 Dec) 776-783
21. Eri R., Kodumudi K.N., Summerlin D.J., and Srinivasan M. Suppression of colon inflammation by CD80 blockade: evaluation in two murine models of inflammatory bowel disease. Inflamm. Bowel. Dis. 14 4 (2008 Apr) 458-470
22. Kim G., Turovskaya O., Levin M., Byrne F.R., Whoriskey J.S., McCabe J.G., and Kronenberg M. Spontaneous colitis occurrence in transgenic mice with altered B7-mediated costimulation. J. Immunol. 181 8 (2008 Oct 15) 5278-5588
23. Seiderer J., Dambacher J., Leistner D., Tillack C., Glas J., Niess J.H., Pfennig S., Jürgens M., Müller-Myhsok B., Göke B., Ochsenkühn T., Lohse P., Reinecker H.C., and Brand S. Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease. Clin. Immunol. 127 1 (2008 Apr) 49-55
24. Lehrke M., Konrad A., Schachinger V., Tillack C., Seibold F., Stark R., Parhofer I.G., and Broedl U.C. CXCL16 is a surrogate marker of inflammatory bowel disease. Scand. J. Gastroenterol. 43 3 (2008 Mar) 283-288
25. Nam S.Y., Kim N., Kim J.S., Lim S.H., Jung H.C., and Song I.S. Heat shock protein gene 70-2 polymorphism is differentially associated with the clinical phenotypes of ulcerative colitis and Crohn's disease. J. Gastroenterol. Hepatol. 22 7 (2007 Jul) 1032-1038
26. Zouiten-Mekki L., Karoui S., Kharrat M., Fekih M., Matri S., Boubaker J., Filali A., and Chaabouni H. Crohn's disease and polymorphism of heat shock protein gene HSP70-2 in the Tunisian population. Eur. J. Gastroenterol. Hepatol. 19 3 (2007 Mar) 225-228
27. Klausz G., Molnár T., Nagy F., Gyulai Z., Boda K., Lonovics J., and Mándi Y. Polymorphism of the heat-shock protein gene Hsp70-2, but not polymorphisms of the IL-10 and CD14 genes, is associated with the outcome of Crohn's disease. Scand. J. Gastroenterol. 40 10 (2005 Oct) 1197-1204
28. Villarino A.V., Artis D., Bezbradica J.S., Miller O., Saris C.J., Joyce S., and Hunter C.A. IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD. Int. Immunol. 20 6 (2008 Jun) 739-752
29. Noble C.L., Nimmo E.R., Drummond H., Ho G.T., Tenesa A., Smith L., Anderson N., Arnott I.D., and Satsangi J. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 129 6 (2005 Dec) 1854-1864
30. Waller S., Tremelling M., Bredin F., Godfrey L., Howson J., and Parkes M. Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Gut 55 6 (2006 Jun) 809-814
31. Shrestha U.K., Karimi O., Crusius J.B., Zhou F., Wang Z., Chen Z., van Bodegraven A.A., Xiao J., Morré S.A., Wang H., Li J., and Xia B. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease. Inflamm. Bowel. Dis. (2009 Aug 27)
32. Dubuquoy L., Jansson E.A., Deeb S., Rakotobe S., Karoui M., Colombel J.F., Auwerx J., Pettersson S., and Desreumaux P. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 124 5 (2003 May) 1265-1276
33. Adachi M., Kurotani R., Morimura K., Shah Y., Sanford M., Madison B.B., Gumucio D.L., Marin H.E., Peters J.M., Young H.A., and Gonzalez F.J. Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut 55 8 (2006 Aug) 1104-1113
34. Lewis J.D., Lichtenstein G.R., Stein R.B., Deren J.J., Judge T.A., Fogt F., Furth E.E., Demissie E.J., Hurd L.B., Su C.G., Keilbaugh S.A., Lazar M.A., and Wu G.D. An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis. Am. J. Gastroenterol. 96 12 (2001 Dec) 3232-3234
35. Fainaru O., Woolf E., Lotem J., Yarmus M., Brenner O., Goldenberg D., Negreanu V., Bernstein Y., Levanon D., Jung S., and Groner Y. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J. 23 4 (2004 Feb 25) 969-979
36. Domínguez-Soto A., Relloso M., Vega M.A., Corbí A.L., and Puig-Kröger A. RUNX3 regulates the activity of the CD11a and CD49d integrin gene promoters. Immunobiology 210 2-4 (2005) 133-139
37. Woolf E., Brenner O., Goldenberg D., Levanon D., and Groner Y. Runx3 regulates dendritic epidermal T cell development. Dev. Biol. 303 2 (2007 Mar 15) 703-714
38. Brady G., and Farrell P.J. RUNX3-mediated repression of RUNX1 in B cells. J. Cell. Physiol. 221 2 (2009 Nov) 283-287
39. Brady G., Whiteman H.J., Spender L.C., and Farrell P.J. Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation. J. Virol. 83 13 (2009 Jul) 6909-6916
40. Setoguchi R., Tachibana M., Naoe Y., Muroi S., Akiyama K., Tezuka C., Okuda T., and Taniuchi I. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319 5864 (2008 Feb 8) 822-825
41. Ohno S., Sato T., Kohu K., Takeda K., Okumura K., Satake M., and Habu S. Runx proteins are involved in regulation of CD122, Ly49 family and IFN-gamma expression during NK cell differentiation. Int. Immunol. 20 1 (2008 Jan) 71-79
42. Delerive P., Fruchart J.C., and Staels B. Peroxisome proliferator-activated receptors in inflammation control. J. Endocrinol. 169 3 (2001 Jun) 453-459
43. Leung E., Hong J., Fraser A.G., Merriman T.R., Vishnu P., and Krissansen G.W. Peroxisome proliferator-activated receptor-gamma gene polymorphisms and Crohn's disease. Int. J. Colorectal. Dis. 22 4 (2007 Apr) 453-454
44. Atug O., Tahan V., Eren F., Tiftikci A., Imeryuz N., Hamzaoglu H.O., and Tozun N. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease. J. Gastrointestin. Liver. Dis. 17 4 (2008 Dec) 433-437
45. Wang F., Tahara T., Arisawa T., Sakata M., Takahama K., Watanabe M., Hirata I., and Nakano H. Polymorphism of peroxisome proliferator-activated receptor gamma is not associated to Japanese ulcerative colitis. Hepatogastroenterology 55 81 (2008 Jan-Feb) 73-75
46. Shrestha U.K., Karimi O., Crusius J.B., Zhou F., Wang Z., Chen Z., van Bodegraven A.A., Xiao J., Morré S.A., Wang H., Li J., and Xia B. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease. Inflamm. Bowel. Dis. (2009 Aug 27) [Electronic publication ahead of print]
47. Helms C., Cao L., Krueger J.G., Wijsman E.M., Chamian F., Gordon D., Heffernan M., Daw J.A., Robarge J., Ott J., Kwok P.Y., Menter A., and Bowcock A.M. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat. Genet. 35 4 (2003 Dec) 349-356
48. Tokuhiro S., Yamada R., Chang X., Suzuki A., Kochi Y., Sawada T., Suzuki M., Nagasaki M., Ohtsuki M., Ono M., Furukawa H., Nagashima M., Yoshino S., Mabuchi A., Sekine A., Saito S., Takahashi A., Tsunoda T., Nakamura Y., and Yamamoto K. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35 4 (2003 Dec) 341-348
49. Prokunina L., Castillejo-López C., Oberg F., Gunnarsson I., Berg L., Magnusson V., Brookes A.J., Tentler D., Kristjansdóttir H., Gröndal G., Bolstad A.I., Svenungsson E., Lundberg I., Sturfelt G., Jönssen A., Truedsson L., Lima G., Alcocer-Varela J., Jonsson R., Gyllensten U.B., Harley J.B., Alarcón-Segovia D., Steinsson K., and Alarcón-Riquelme M.E. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32 4 (2002 Dec) 666-669
50. Li M., Gao X., Guo C.C., Wu K.C., Zhang X., and Hu P.J. OCTN and CARD15 gene polymorphism in Chinese patients with inflammatory bowel disease. World J. Gastroenterol. 14 31 (2008 Aug 21) 4923-4927
51. Okada Y., Mori M., Yamada R., Suzuki A., Kobayashi K., Kubo M., Nakamura Y., and Yamamoto K. SLC22A4 polymorphism and rheumatoid arthritis susceptibility: a replication study in a Japanese population and a metaanalysis. J. Rheumatol. 35 9 (2008 Sep) 1723-1728
52. Wojtal K.A., Eloranta J.J., Hruz P., Gutmann H., Drewe J., Staumann A., Beglinger C., Fried M., Kullak-Ublick G.A., and Vavricka S.R. Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients. Drug Metab. Dispos. 37 9 (2009 Sep) 1871-1877
53. Seidman1 E., Girardin1 M., Goyette P., Rioux J., Dionne1 S., Charlebois1 P., and Qureshi I. Expression and functional analysis of intestinal organic cation/L-carnitine transporter (OCTN) in Crohn's disease. CDDW (2009) Abstracts No. 178
54. Kotka M., Lieden A., Pettersson S., Trinchieri V., Masci A., and D'Amato M. Solute carriers (SLC) in inflammatory bowel disease: a potential target of probiotics?. J. Clin. Gastroenterol. 42 Suppl. 3 Pt. 1 (2008 Sep) S133-S135